Merck (MRK) EPS (Basic) Growth (5y) (2014 - 2026)
Merck (MRK) EPS (Basic) Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.85 Bn | 633.09 Bn | 17.26 Bn |
| 2 | AbbVie | 471.53 Bn | 464.96 Bn | 12.70 Bn |
| 3 | Merck | 380.02 Bn | 372.88 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.58 Bn | 295.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.47 Bn | 253.57 Bn | 12.86 Bn |
| 6 | Amgen | 237.24 Bn | 223.25 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.09 Bn | 179.91 Bn | 6.22 Bn |
| 8 | Pfizer | 161.82 Bn | 150.12 Bn | 10.94 Bn |
| 9 | Gsk | 105.93 Bn | 101.77 Bn | 8.24 Bn |
| 10 | Sanofi | 55.25 Bn | 47.87 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -43.71% |
| Mar 31, 2026 | -64.18% |
| Dec 31, 2025 | 41.77% |
| Sep 30, 2025 | 56.79% |
| Jun 30, 2025 | 46.31% |
| Mar 31, 2025 | 9.66% |
| Dec 31, 2024 | 32.59% |
| Sep 30, 2024 | 10.84% |
| Jun 30, 2024 | 15.97% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | -22.19% |
| Sep 30, 2023 | 20.55% |
| Jun 30, 2023 | -41.52% |
| Mar 31, 2023 | 32.27% |
| Dec 31, 2021 | 35.70% |
| Jun 30, 2021 | -21.40% |
| Mar 31, 2021 | -15.89% |
| Dec 31, 2020 | -9.93% |
| Sep 30, 2020 | -17.76% |
| Jun 30, 2020 | 1.57% |